Bartell Drugs

iMerge Advisors is a Seattle-based M&A advisory firm with a focus on the software and technology sectors, celebrating 25 years of providing expert guidance to founders seeking to sell their companies. With a personalized, founder-first approach and a proven track record of completing transactions ranging from $3 million to $50 million, iMerge is dedicated to helping clients unlock their companies' true value and navigate the complexities of the M&A process. Leveraging extensive experience and connections to both strategic and financial buyers globally, iMerge Advisors ensures a confidential and efficient process from growth strategy to closing. Their dedicated team of M&A consultants acts as primary points of contact, enabling tailored messaging and maximizing outcomes for clients as they explore exit options and strategic opportunities. Generated from the website

Tax and Accounting Services